Gut Microbiota Reconstruction for NSCLC Immunotherapy

NCT05008861 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

PROCEDURE: Capsulized Fecal Microbiota Transplant
DRUG: Anti-programmed cell death protein 1/programmed death-ligand 1 monoclonal antibody
DRUG: Platinum based chemotherapy

Sponsor

Shanghai Zhongshan Hospital